| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Centre for Diabetes and Endocrinology, Department of Medicine, Rayne Institute, and
Centre for Research on Ageing, Department of Biology, University College London, London, UK;
Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge, UK;
European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK;
|| Aberdeen Centre for Energy Regulation and Obesity (ACERO), School of Biological Sciences, University of Aberdeen, Aberdeen, UK; and
¶ Division of Molecular Neuroendocrinology, Medical Research Council National Institute of Medical Research, London, UK
1Correspondence: Centre for Diabetes and Endocrinology, Rayne Institute, University College London, University St., London, UK. E-mail: d.withers{at}ucl.ac.uk
Recent evidence suggests that alterations in insulin/insulin-like growth factor 1 (IGF1) signaling (IIS) can increase mammalian life span. For example, in several mouse mutants, impairment of the growth hormone (GH)/IGF1 axis increases life span and also insulin sensitivity. However, the intracellular signaling route to altered mammalian aging remains unclear. We therefore measured the life span of mice lacking either insulin receptor substrate (IRS) 1 or 2, the major intracellular effectors of the IIS receptors. Our provisional results indicate that female Irs1–/– mice are long-lived. Furthermore, they displayed resistance to a range of age-sensitive markers of aging including skin, bone, immune, and motor dysfunction. These improvements in health were seen despite mild, lifelong insulin resistance. Thus, enhanced insulin sensitivity is not a prerequisite for IIS mutant longevity. Irs1–/– female mice also displayed normal anterior pituitary function, distinguishing them from long-lived somatotrophic axis mutants. In contrast, Irs2–/– mice were short-lived, whereas Irs1+/– and Irs2+/– mice of both sexes showed normal life spans. Our results therefore suggest that IRS1 signaling is an evolutionarily conserved pathway regulating mammalian life span and may be a point of intervention for therapies with the potential to delay age-related processes.—Selman, C., Lingard, S., Choudhury, A. I., Batterham, A. L., Claret, M., Clements, M., Ramadani, F., Okkenhaug, K., Schuster, E., Blanc, E., Piper, M. D., Al-Qassab, H., Speakman, J. R., Carmignac, D., Robinson, I. C. A., Thornton, J. M., Gems, D., Partridge, L., Withers, D. J. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice.
Key Words: aging • longevity • insulin signaling
This article has been cited by other articles:
|
|
 |
|
  S. Alper, M. K. McElwee, J. Apfeld, B. Lackford, J. H. Freedman, and D. A. Schwartz The Caenorhabditis elegans Germ Line Regulates Distinct Signaling Pathways to Control Lifespan and Innate Immunity J. Biol. Chem., January 15, 2010; 285(3): 1822 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Partridge The new biology of ageing Phil Trans R Soc B, January 12, 2010; 365(1537): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ikeya, S. Broughton, N. Alic, R. Grandison, and L. Partridge The endosymbiont Wolbachia increases insulin/IGF-like signalling in Drosophila Proc R Soc B, November 7, 2009; 276(1674): 3799 - 3807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Selman, J. M. A. Tullet, D. Wieser, E. Irvine, S. J. Lingard, A. I. Choudhury, M. Claret, H. Al-Qassab, D. Carmignac, F. Ramadani, et al. Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span Science, October 2, 2009; 326(5949): 140 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Freude, M. M. Hettich, C. Schumann, O. Stohr, L. Koch, C. Kohler, M. Udelhoven, U. Leeser, M. Muller, N. Kubota, et al. Neuronal IGF-1 resistance reduces A{beta} accumulation and protects against premature death in a model of Alzheimer's disease FASEB J, October 1, 2009; 23(10): 3315 - 3324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Thorner Statement by the Growth Hormone Research Society on the GH/IGF-I Axis in Extending Health Span J Gerontol A Biol Sci Med Sci, October 1, 2009; 64A(10): 1039 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Geraldes, K. Yagi, Y. Ohshiro, Z. He, Y. Maeno, J. Yamamoto-Hiraoka, C. Rask-Madsen, S. W. Chung, M. A. Perrella, and G. L. King Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 Pathway J. Biol. Chem., December 5, 2008; 283(49): 34327 - 34336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Willcox, T. A. Donlon, Q. He, R. Chen, J. S. Grove, K. Yano, K. H. Masaki, D. C. Willcox, B. Rodriguez, and J. D. Curb FOXO3A genotype is strongly associated with human longevity PNAS, September 16, 2008; 105(37): 13987 - 13992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N Butler, R. A Miller, D. Perry, B. A Carnes, T F. Williams, C. Cassel, J. Brody, M. A Bernard, L. Partridge, T. Kirkwood, et al. New model of health promotion and disease prevention for the 21st century BMJ, July 8, 2008; 337(jul08_3): a399 - a399. [Full Text]
|
|
|
|
|
|
C. Selman, S. Lingard, D. Gems, L. Partridge, and D. J. Withers Comment on "Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis" Science, May 23, 2008; 320(5879): 1012b - 1012b. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Taguchi and M. F. White Response to Comment on "Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis" Science, May 23, 2008; 320(5879): 1012c - 1012c. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
